Delivery Order SPE2DB22D2006-SPE2DB25FW3RN
- Not listed
- The Defense Logistics Agency awarded a $22,459.46 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Multaq 400 mg tablets (60-count units). This is a firm fixed-price contract with an ultimate completion date of August 14, 2025, and represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Multaq 400 mg tablets (60-count packages) valued at $92,596.99. This firm fixed-price delivery order represents a competitive award with no set-aside designation and has an ultimate completion date of August 27, 2025. The contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $11,985.90. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order, with an ultimate completion date of August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Multaq 400 mg tablets (60-count units) valued at $7,902.75 under a firm fixed-price contract. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal medical supply needs, with an ultimate completion date of August 15, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $3,405.18 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Multaq 400 mg tablets (60-count). The contract is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a non-set-aside, competitively awarded transaction, reflecting the contractor's established capability to meet federal...
- The Defense Logistics Agency awarded a delivery order valued at $37,333.81 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on July 15, 2025, with an ultimate completion date of July 16, 2025. The contract utilizes firm fixed pricing and was competitively awarded without a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Multaq 400 mg tablets (60-count units) valued at $7,899.11 on August 26, 2025, with an ultimate completion date of August 27, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger federal contract vehicle. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $53,458.59 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count packages) with a firm fixed price arrangement. This competitively awarded, non-set-aside contract is scheduled for completion by August 27, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $13,188.00 to AmerisourceBergen Drug Corp for the supply of Multaq 400 mg tablets (60-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. The award represents a single delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a $57,770.08 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Multaq 400 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 4, 2025, with performance based in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and veteran...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB25FW3RNDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $27,536.90 on August 18, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract operates under a firm fixed-price arrangement with an ultimate completion date of August 19, 2025, and represents a non-set-aside competitive award. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, supplying the Defense Health Agency and other military healthcare systems with a comprehensive range of pharmaceutical products and medical supplies. The parent IDC enables the company to deliver pharmaceuticals and medical commodities globally in support of military healthcare programs, with the DLA planning to establish additional regional pharmaceutical prime vendor contracts under its Generation V initiative.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.5k | 8/18/25 |